Delivery Order SPE2DB20D7059-SPE2DB24FQKZ2

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,647.84 firm fixed-price delivery order is for the medical product DIPRIVAN 1,000 MG/100 ML VIAL 100ML, with a completion date of July 2, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,303.02, is for the delivery of DIPRIVAN 200 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,075.38 firm fixed-price delivery order is for the supply of DIPRIVAN 200 MG/20 ML VIAL 20ML, a medical product, with a period of performance through March 4, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,173.47 for the product "DIPRIVAN 200 MG/20 ML VIAL 20ML". The award has an ultimate completion date of February 27, 2025 and is a Firm Fixed Price contract. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
This is a $2,161.86 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical commodity, to support military healthcare programs. The contract has an ultimate completion date of April 30, 2024 and is a firm fixed-price contract. This award is associated with a larger $999,999,999 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,072.54 firm-fixed-price delivery order is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award is for the delivery of DIPRIVAN 200 MG/20 ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has an award value of $1,318.32 and a completion date of September 14, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,340.24 firm fixed-price delivery order is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a pharmaceutical product, with an ultimate completion date of February 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The award, with a ceiling value of $2,360.54, is for the delivery of DIPRIVAN 500 MG/50 ML VIAL 50ML, a critical medical commodity. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 4, 2025. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite...
This federal contract award, valued at $3,156.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FQKZ2
    Delivery Order

This federal contract award, valued at $2,194.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of DIPRIVAN 200 MG/20 ML VIAL 20ML, a pharmaceutical product. The award has an ultimate completion date of August 12, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at up to $999,999,999 through December 2025. The IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and other pharmaceutical and medical supplies, to support military treatment programs and facilities worldwide. The contract award did not utilize a set-aside designation.

Generated 11/8/24, 9:02 AM